Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

CorMedix (CRMD) Shares Outstanding (Diluted Average): 2014-2025

Historic Shares Outstanding (Diluted Average) for CorMedix (CRMD) over the last 4 years, with Jun 2025 value amounting to $71.9 million.

  • CorMedix's Shares Outstanding (Diluted Average) rose 24.81% to $71.9 million in Q2 2025 from the same period last year, while for Jun 2025 it was $71.9 million, marking a year-over-year increase of 24.81%. This contributed to the annual value of $58.9 million for FY2024, which is N/A change from last year.
  • Per CorMedix's latest filing, its Shares Outstanding (Diluted Average) stood at $71.9 million for Q2 2025, which was up 4.27% from $69.0 million recorded in Q1 2025.
  • Over the past 5 years, CorMedix's Shares Outstanding (Diluted Average) peaked at $71.9 million during Q2 2025, and registered a low of $37.7 million during Q4 2021.
  • For the 3-year period, CorMedix's Shares Outstanding (Diluted Average) averaged around $57.7 million, with its median value being $57.6 million (2024).
  • Data for CorMedix's Shares Outstanding (Diluted Average) shows a peak YoY spiked of 37.32% (in 2023) over the last 5 years.
  • CorMedix's Shares Outstanding (Diluted Average) (Quarterly) stood at $37.7 million in 2021, then increased by 6.92% to $40.3 million in 2022, then spiked by 37.32% to $56.6 million in 2023, then increased by 4.02% to $58.9 million in 2024, then rose by 24.81% to $71.9 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $71.9 million for Q2 2025, versus $69.0 million for Q1 2025 and $58.9 million for Q4 2024.